INMED PHARMACEUTICALS INC's ticker is and the CUSIP is 457637601. A total of 15 filers reported holding INMED PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,000 | – | 1,067 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 17,724 | $36 | 0.01% |
| ARMISTICE CAPITAL, LLC | 97,163 | $196,269 | 0.00% |
| ROYAL BANK OF CANADA | 11 | $0 | 0.00% |
| Advisory Services Network, LLC | 6 | $12 | 0.00% |
| TCI Wealth Advisors, Inc. | 5 | $10 | 0.00% |
| UBS Group AG | 831 | $1,679 | 0.00% |
| AllSquare Wealth Management LLC | 21 | $42 | 0.00% |
| OSAIC HOLDINGS, INC. | 74 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 1 | $2 | 0.00% |